Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.
Costantini A, Julie C, Dumenil C, Hélias-Rodzewicz Z, Tisserand J, Dumoulin J, Giraud V, Labrune S, Chinet T, Emile JF, Giroux Leprieur E.
Costantini A, et al. Among authors: chinet t.
Oncoimmunology. 2018 Apr 20;7(8):e1452581. doi: 10.1080/2162402X.2018.1452581. eCollection 2018.
Oncoimmunology. 2018.
PMID: 30221046
Free PMC article.